Preparation method and application of Chinese herbal medicine fermentation liquor
Through the endogenous bacterial fermentation technology of Rhodiola, the problems of organic solvent pollution and low utilization rate of active ingredients in Chinese herbal extract were solved, and the efficient anti-inflammatory effect and high utilization rate of Chinese herbal medicine were achieved, which was significantly better than traditional methods.
Patent Information
- Application Number
- CN202410954981.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2024-11-26
AI Technical Summary
Various organic solvents are used in the existing Chinese herbal extraction methods, which lead to contamination and toxicity problems. At the same time, the utilization rate of active ingredients of Chinese herbal medicine is low and the efficacy is not ideal, making it difficult to improve the quality and efficacy of Chinese herbal medicine.
The fermentation of Chinese herbal medicines is carried out by using the yeast Kalibike Meyer, which is isolated from the large flower of Rhodiola. Through the fermentation process, Chinese herbal medicines such as hops, Ophiopogon japonicus, Prince Ginseng and Rock Candy Grass are used to improve Chinese herbal medicines by using the fermentation ability of yeasts. anti-inflammatory effects and reduce dependence on organic solvents.
It has achieved the efficient anti-inflammatory effect of Chinese herbal medicine, significantly improved the utilization rate and efficacy of Chinese herbal medicine, reduced the use of organic solvents, avoided contamination and toxicity problems, and the fermentation products obtained at the same time have significant anti-inflammatory effects, which are better than traditional methods. .
Smart Images

Figure CN119015195A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of cosmetics, in particular to an endophyte of Rhodiola rosea and a method for preparing a Chinese herbal medicine fermentation product using the endophyte. The present invention further relates to the use of the fermentation product in a pharmaceutical composition or a cosmetic composition. Background Art
[0002] Chinese herbal medicine fermentation is a process of fermentation using microorganisms with Chinese herbal medicine as substrate. Active substances will be enriched during the fermentation process, and active ingredients may also be modified or transformed during the fermentation process, causing changes in solubility or efficacy components, reducing toxic side effects, and antioxidants and antioxidant enzymes secreted by microorganisms can protect active substances from oxidation, making them easier to use. The metabolites of microbial fermentation may also enhance the efficacy of drugs through synergistic effects with drug ingredients. The mild conditions of fermentation and its high quality and low price have also laid the foundation for its widespread development and application.
[0003] Endophytes in Chinese herbal medicines refer to microorganisms that parasitize inside the plant tissues of Chinese herbal medicines. Chinese herbal medicines have a significant impact on endophytes. Their unique chemical composition and ecological environment provide endophytes with rich nutrition and special living conditions, thereby promoting the diversity and functional characteristics of endophytes. Unlike other types of microorganisms, endophytes live inside plant tissues and form a symbiotic relationship with the host. They can not only promote the growth of Chinese herbal medicines and enhance disease resistance, but also synthesize secondary metabolites similar to or complementary to those of the host plants, such as alkaloids, flavonoids and polysaccharides, which often have significant pharmacological activities. In addition, these endophytes have strong fermentation ability and improve the bioavailability and pharmacological effects of Chinese herbal medicines through biotransformation. Research and utilization of endophytes in Chinese herbal medicines has become an important direction for improving the quality of Chinese herbal medicines and developing new sources of medicine.
[0004] According to the theory of the compatibility system of "monarch, minister, assistant and envoy" in traditional Chinese medicine, the present invention combines the above Chinese herbal medicines with similar or synergistic effects in a certain proportion, and obtains a fermentation liquid with stronger anti-inflammatory effect by fermentation with Rhodiola rosea endogenous bacteria for the first time. Compared with traditional Chinese herbal medicine extracts, this method reduces the use of multiple organic solvents, avoids organic pollution and toxicity problems, and improves the utilization rate of Chinese herbal medicines. Summary of the invention
[0005] The present invention discloses for the first time endophytes separated from Rhodiola rosea and applications thereof, provides a method for preparing Chinese herbal medicine fermentation products by using the endophytes, and the Chinese herbal medicine fermentation products obtained by the method and applications thereof.
[0006] In some aspects, the present invention provides a method for fermenting Chinese herbal medicine using Meyerozyma caribbica isolated from Rhodiola rosea, comprising:
[0007] The herbal material is fermented in the presence of the Saccharomyces cerevisiae at 25°C-40°C for 10-50 hours.
[0008] The Chinese herbal material can be a whole plant, or one or more parts of a plant, such as flowers, leaves, stems and roots. In some embodiments, the Chinese herbal material is washed, dried, chopped / crushed.
[0009] In some embodiments, the Chinese herbal material is sieved through a sieve, preferably, the sieve is a 100 mesh sieve.
[0010] In some embodiments, the Chinese herbal material is a suspension or slurry after being mixed with water, preferably, the total material-to-liquid ratio of the suspension or slurry is 15-25 g / L, such as 20 g / L. The suspension or slurry is preferably sterilized before fermentation.
[0011] In some embodiments, the Chinese herbal medicine is selected from hops, ophiopogon japonicus, Pseudostellaria heterophylla and rock candy grass. For example, the Chinese herbal medicine can be any one or more of hops, ophiopogon japonicus, Pseudostellaria heterophylla and rock candy grass.
[0012] In some embodiments, the Chinese herbal medicine is a combination of hops, ophiopogon japonicus, pseudoginseng and rock candy grass. Preferably, the weight ratio of hops to ophiopogon japonicus, pseudoginseng and rock candy grass in the Chinese herbal medicine materials is 1:1. More specifically, the weight ratio of hops, ophiopogon japonicus, pseudoginseng and rock candy grass is 4:2:1:1, 4:1:2:1 or 4:1:1:2, more preferably 4:1:1:2.
[0013] In some embodiments, the Kalibik Maye Saccharomyces cerevisiae is Kalibik Maye Saccharomyces PEY-2, which was deposited in the China Center for Type Culture Collection on May 17, 2024, with the strain accession number of CCTCC M 2024991.
[0014] In some embodiments, the Mayer Saccharomyces californica is provided in the form of a bacterial suspension of a culture, and optionally, the bacterial suspension is a secondary seed liquid after seed expansion culture.
[0015] In some embodiments, the culture is a culture of the M. carlibikerii in YPD medium.
[0016] In some embodiments, a bacterial suspension of Saccharomyces californica is inoculated into a fermentation device containing the Chinese herbal medicine material for fermentation. Preferably, the bacterial suspension is inoculated into the fermentation device at 8% of the total fermentation volume.
[0017] In some embodiments, the fermentation apparatus is a fermentor, such as a rotary fermentor.
[0018] In some embodiments, the fermentation is carried out at a temperature of 25°C-37°C, preferably at a temperature of 30°C.
[0019] In some embodiments, the fermentation time is 16 hours to 40 hours, preferably 32 hours.
[0020] In some embodiments, the fermentation broth after fermentation is further subjected to impurity and sterilization, for example, by centrifugation and membrane separation.
[0021] In some embodiments, the method comprises:
[0022] a) growing the Meyer yeast Kalibik isolated from Rhodiola rosea in a culture medium to prepare a bacterial suspension;
[0023] b) adding Chinese herbal medicine material into a fermentation device; and
[0024] c) inoculating the bacterial suspension from step a) into a fermentation device for fermentation.
[0025] In some embodiments, the Chinese herbal medicine is a combination of hops, ophiopogon japonicus, pseudoginseng and rock candy grass, and the fermentation is carried out at a temperature of 30°C for 32 hours. Preferably, the weight ratio of hops, ophiopogon japonicus, pseudoginseng and rock candy grass in the Chinese herbal medicine materials is 4:2:1:1, 4:1:2:1 or 4:1:1:2, more preferably 4:1:1:2.
[0026] In some aspects, the present invention provides a Chinese herbal medicine fermentation product obtained by any of the methods disclosed herein.
[0027] In some embodiments, the Chinese herbal medicine is a combination of hops, ophiopogon japonicus, pseudoginseng and rock candy grass, wherein the weight ratio of hops, ophiopogon japonicus, pseudoginseng and rock candy grass is 4:2:1:1, 4:1:2:1 or 4:1:1:2, preferably 4:1:1:2.
[0028] In some aspects, the present invention provides a pharmaceutical composition comprising the Chinese herbal medicine fermentation product disclosed herein.
[0029] In some aspects, the present invention provides a cosmetic composition comprising the Chinese herbal medicine fermentation product disclosed herein.
[0030] In some embodiments, the cosmetic composition further comprises a cosmetically acceptable excipient or a dermatologically acceptable carrier, and optionally additional cosmetically active ingredients, such as vitamins, colorants or fragrances.
[0031] In some embodiments, the cosmetic composition is formulated in the form of a solution, suspension, emulsion, paste, gel, cream, spray, or serum, or incorporated into a facial mask.
[0032] In some aspects, the present invention relates to the use of the Chinese herbal medicine fermentation product disclosed herein in the preparation of a medicament for preventing, alleviating or improving skin inflammation.
[0033] In some aspects, the present invention relates to the use of the Chinese herbal fermentation product disclosed herein in the preparation of skin care products or cosmetics with anti-inflammatory effects.
[0034] In some aspects, the present invention provides a Mycosaccharomyces calibicolor isolated from Rhodiola rosea, which was deposited in the China Center for Type Culture Collection on May 17, 2024, and the strain collection number is CCTCC M 2024991.
[0035] In some aspects, the present invention relates to the use of the Saccharomyces cerevisiae disclosed herein in preparing a fermentation product of a Chinese herbal medicine.
[0036] In some aspects, the present invention provides a method for isolating a plant endophyte, the method comprising:
[0037] a) separating and homogenizing the flowers, leaves, stems and roots of the whole plant;
[0038] b) inoculating the tissue homogenate into liquid culture medium for culturing;
[0039] c) streaking the culture from step b) onto solid medium; and
[0040] d) identifying the colonies from step c). BRIEF DESCRIPTION OF THE DRAWINGS
[0041] Figure 1 Phylogenetic tree for species identification of M. californica PEY-2. DETAILED DESCRIPTION
[0042] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by those of ordinary skill in the art to which the present disclosure belongs. All patents, patent applications and other publications cited herein are incorporated by reference in their entirety. If a definition set forth herein conflicts with a definition set forth in a patent, patent application and other publication incorporated herein by reference, the definition set forth herein shall prevail.
[0043] As used herein, the term "seed liquid" refers to a bacterial suspension containing a sufficient number of microorganisms obtained after the microorganisms used in the fermentation process are cultured from seeds. The method of culture from seeds of microorganisms is well known to those skilled in the art.
[0044] As used in this article, "Chinese herbal medicine", "medicinal plants" and "botanicals" are used interchangeably and refer to plants that have certain pharmacological activities and can be used in medicine to prevent and treat diseases. All or part of the plants can be used for medicinal purposes or as raw materials for the pharmaceutical industry. For example, plants with anti-inflammatory, antioxidant and other effects include but are not limited to Ophiopogon japonicus, Hops, Pseudostellaria baicalensis and Rock Candy Grass.
[0045] As used herein, the terms "Chinese herbal medicine fermentation liquid" and "Chinese herbal medicine fermentation product" are used interchangeably and refer to a fermentation product obtained by fermenting Chinese herbal medicine as a substrate using microorganisms. The fermentation product can be a fermentation product using a single Chinese herbal medicine as a substrate (i.e., a single fermentation product) or a fermentation product using multiple Chinese herbal medicines as substrates (i.e., a compound fermentation product), wherein different types of Chinese herbal medicines are mixed in a certain proportion.
[0046] As used in this article, the term "compatibility" refers to the main form of Chinese medicine medication, which is to select and apply corresponding theoretical principles based on the therapeutic purpose and medicinal properties, and adopt two or more Chinese medicines to combine into a prescription to increase efficacy, reduce toxicity and improve efficacy.
[0047] Endophytes isolated from Rhodiola rosea
[0048] Endophytes are an important type of biological resource that exists inside plant tissues but does not have a negative impact on plants. Endophytes in Chinese herbal medicines can not only promote the growth of Chinese herbal medicines and enhance disease resistance, but also synthesize secondary metabolites similar to or complementary to those of the host plants, such as alkaloids, flavonoids and polysaccharides, which often have significant pharmacological activities. In addition, these endophytes have strong fermentation capabilities and improve the bioavailability and pharmacological effects of Chinese herbal medicines through biotransformation.
[0049] In some aspects, the present invention provides an endophyte isolated from Rhodiola rosea, more specifically Meyerozyma caribbica. Rhodiola rosea is distributed in Tibet, northwest Yunnan, western Sichuan and other places in China. It can be propagated by rhizome cuttings and division, or by test tube technology. Rhodiola rosea contains pharmacologically active ingredients such as salidrosides, polysaccharides, and flavonoid compounds, and can be used as a medicinal plant with antioxidant, anti-inflammatory, anti-fatigue and anti-hypoxia effects. The endophytic fungi in different organs (roots, stems, and leaves) of Rhodiola rosea are rich in species diversity, among which there are differences in the dominant strains in the roots, stems, and leaves, and the diversity of endophytic fungi in the stems is the highest, suggesting that the endophytic fungi in Rhodiola rosea have a wide range of potential application value. In the present application, the inventors isolated a specific Kalibik Mayer yeast PEY-2 from Rhodiola rosea for the first time, which was deposited in the China Center for Type Culture Collection (address: Wuhan University) on May 17, 2024, with the strain deposit number of CCTCC M 2024991. As verified in the examples, the endophyte can be used to ferment a variety of Chinese herbal medicines, and the fermentation products produced have improved anti-inflammatory effects and can effectively inhibit the secretion of inflammatory factors (such as IL-6) of macrophages.
[0050] In some embodiments, the strain is cultured in a culture medium (e.g., YPD culture medium) and prepared into a seed solution for subsequent use. The seed solution may be a primary seed solution, or a secondary seed solution prepared by further inoculating and culturing the primary seed solution.
[0051] Fermentation of Chinese herbal medicines
[0052] As a natural traditional medicine, Chinese herbal medicine has a variety of active substances and is widely used in daily life such as disease prevention and treatment, medical care, etc. Most Chinese herbal medicines are plant-derived medicinal materials. Their active ingredients are relatively complex and mostly exist in the cell cytoplasm. They are hindered by the dense structures of cellulose, hemicellulose and lignin in the plant cell wall, which makes it difficult to extract the active ingredients of Chinese herbal medicines, the utilization rate of the effective ingredients is low, and the efficacy is not ideal, resulting in resource waste, which to a certain extent restricts the development of Chinese herbal medicines. Chinese herbal medicine fermentation is a process of fermenting Chinese herbal medicines with microorganisms as substrates under appropriate conditions of temperature, humidity, pH and water. Using microorganisms to ferment Chinese herbal medicines can promote the release of active substances in Chinese herbal medicines, reduce the toxicity of Chinese herbal medicines and reduce toxic and side effects, so that Chinese herbal medicines produce antibacterial activity and new active ingredients. In addition, the enzymes in the fermentation matrix can decompose macromolecules, making the active ingredients of Chinese herbal medicines easier to be absorbed and utilized by the body.
[0053] In addition, due to their similarities and complementarity with the host in metabolism, endophytes of Chinese herbal medicines have unique advantages in the fermentation of Chinese herbal medicines. The use of endophytes in Chinese herbal medicines for fermentation of Chinese herbal medicines has broad application prospects in improving the quality of Chinese herbal medicines and increasing the utilization rate of Chinese herbal medicines.
[0054] In some aspects, the present invention provides a method for fermenting a material derived from a Chinese herbal medicine, the method comprising culturing the material derived from the Chinese herbal medicine together with Meyer yeast isolated from Rhodiola rosea in a culture medium.
[0055] In some embodiments, the method comprises: adding materials derived from Chinese herbal medicine to a fermentation device; and inoculating a bacterial suspension of Saccharomyces cerevisiae isolated from Rhodiola rosea into the fermentation device for fermentation. Preferably, the Chinese herbal medicine material is pretreated, such as washing, drying, chopping / crushing, sieving, etc. Further, before inoculating the strain, the pretreated Chinese herbal medicine material is evenly mixed with water to prepare a suspension, solution or slurry. Preferably, the suspension, solution or slurry is subjected to a sterilization operation, such as high temperature and / or high pressure sterilization. The Chinese herbal medicine is not limited to hops, ophiopogon japonicus, Pseudostellaria heterophylla and crystal sugar grass used in the present invention, but can be applied to a variety of other Chinese herbal medicines.
[0056] According to factors such as the concentration of the reactants in the fermentation temperature, the fermentation system, and the scale of the fermentation, the fermentation time can vary within a certain range. In some embodiments, the fermentation time is about 10-50 hours (including any sub-range and endpoint therein), for example, about 16-40 hours. In some specific embodiments, the fermentation time is about 16-20 hours, 20-24 hours, 24-28 hours, 28-32 hours, 32-36 hours or 36-40 hours. In a preferred embodiment, the fermentation time is 32 hours. The fermentation temperature can also vary with the concentration of the reactants in the fermentation system, the scale of the fermentation, the fermentation time, etc. In some embodiments, the fermentation is carried out at a temperature of about 25°C-37°C (including any sub-range and endpoint therein), for example, about 25°C, 30°C, 33°C, 37°C. In a preferred embodiment, the fermentation is carried out at a temperature of 30°C.
[0057] In some embodiments, the fermentation is carried out at a temperature of about 25° C. to 37° C. for about 10 to 50 hours. The fermentation scale can be a small-scale production adopted in laboratory research or a large-scale production on an industrial scale. The appropriate fermentation scale can be selected as needed.
[0058] Anti-inflammatory effects of Chinese herbal medicine
[0059] Clinical and experimental evidence confirms that many Chinese herbal medicines have good anti-inflammatory effects. The active ingredients of Chinese herbal medicines with anti-inflammatory effects include alkaloids, glycosides, polysaccharides, etc. Common alkaloids with anti-inflammatory effects include tetrandrine, matrine, berberine, triptolide, etc. Common glycosides with anti-inflammatory effects include saponins, flavonoid glycosides, coumarin glycosides, etc., such as triptolide polyglycosides, bupleurum total glycosides, notoginseng total saponins, ginsenosides, etc.; polysaccharides with anti-inflammatory effects include astragalus polysaccharides, ganoderma lucidum polysaccharides, ginseng polysaccharides, and wolfberry polysaccharides. Ophiopogon japonicus, hops, Pseudostellaria heterophylla, and crystal sugar grass are rich in active ingredients such as saponins, flavonoids, and polysaccharides, and have anti-inflammatory and antioxidant effects.
[0060] Generally, Chinese herbal medicines are used in the form of decoctions or by extraction (e.g., decoction, reflux, maceration, percolation, etc.). The inventors found that the fermentation products obtained by fermenting Chinese herbal medicines with the yeast Carlibikerella isolated from Rhodiola rosea have significantly improved anti-inflammatory effects compared to the fermentation products without the yeast, thereby improving the utilization rate of Chinese herbal medicines.
[0061] In some embodiments of the present application, by combining hops, ophiopogon japonicus, pseudostellaria and rock sugar grass in a certain proportion and applying them to Chinese herbal medicine fermentation, the obtained compound fermentation product has the effect of synergistically improving the anti-inflammatory effect.
[0062] In some aspects, the present invention provides a method for preparing a Chinese herbal fermentation product, comprising: a) growing the Kalibik Mayer yeast isolated from Rhodiola rosea in a culture medium to prepare a bacterial suspension of the yeast; b) adding a material derived from Chinese herbal medicine to a fermentation device; c) inoculating the bacterial suspension from step a) into the fermentation device for fermentation; and d) purifying and aseptically treating the fermentation broth from step c) to obtain a fermentation product. Preferably, the Kalibik Mayer yeast isolated from Rhodiola rosea is Kalibik Mayer yeast PEY-2. The culture medium can be any culture medium suitable for yeast growth, such as YPD culture medium. Preferably, the bacterial suspension is a secondary seed liquid after seed expansion culture. The material derived from Chinese herbal medicine can be a Chinese herbal medicine powder obtained by drying and pulverizing Chinese herbal medicine plants, and the obtained powder can be optionally sieved through a sieve (e.g., a 100-mesh sieve) and prepared as a suspension.
[0063] In some aspects, the present invention relates to a Chinese herbal medicine fermentation product obtained by the method disclosed herein. The Chinese herbal medicine fermentation product may be a fermentation product selected from one or more of hops, ophiopogon japonicus, Pseudostellaria sibiricum and rock candy grass. In a preferred embodiment, the Chinese herbal medicine fermentation product comprises a fermentation product of hops, ophiopogon japonicus, Pseudostellaria sibiricum and rock candy grass, wherein hops, ophiopogon japonicus, Pseudostellaria sibiricum and rock candy grass are mixed in a ratio of 4:2:1:1, 4:1:2:1 or 4:1:1:2. In some embodiments, hops are fermented using the method of the present invention, and the resulting fermentation product is a hop fermentation broth. In some embodiments, ophiopogon japonicus is fermented using the method of the present invention, and the resulting fermentation product is a ophiopogon japonicus fermentation broth. In some embodiments, Pseudostellaria sibiricum is fermented using the method of the present invention, and the resulting fermentation product is a Pseudostellaria sibiricum fermentation broth. In some embodiments, rock candy grass is fermented using the method of the present invention, and the resulting fermentation product is a rock candy grass fermentation broth.
[0064] In a preferred embodiment, hops, ophiopogon japonicus, pseudoginseng and rock sugar grass are mixed in a ratio of 4:1:1:2 to prepare a 20 g / L suspension, and the secondary seed liquid of Kalibik Mayer yeast PEY-2 is inoculated at 8% of the total fermentation volume. The fermentation is carried out at a temperature of 30°C for 32 hours. The obtained composite fermentation product has excellent anti-inflammatory effect, and its effect is significantly stronger than that of the positive control dexamethasone (100 ng / mL).
[0065] Inflammation Model
[0066] Inflammation is a defensive reaction of the body after being stimulated and damaged by various inflammatory factors. The macrophage system is the central cell that initiates the production of inflammatory mediators in the body and is the main cell that regulates the inflammatory response. Lipopolysaccharide (LPS) is an important trigger of inflammatory response and induces a variety of cytokines to participate in the inflammatory response. Therefore, the LPS-activated mouse mononuclear macrophage leukemia cell (RAW264.7) inflammation model is widely used in the study of inflammatory response. After LPS acts on macrophages, it can bind to Toll-like receptor 4 (TLR4) on the cell surface, activate nuclear transcription factor NF-κB and activator protein 1 (AP-1) through a series of signal transduction pathways, and induce the expression and release of a large number of inflammatory factors (such as TNF-α, IL-1, IL-6, IL-8 and IL-12, etc.). IL-6 can promote B cell differentiation, activate mitogen-activated protein kinases, activate signal transducers and transcription activators, and aggravate the inflammatory response process. It has been confirmed that a variety of inflammatory-related diseases are accompanied by a significant increase in IL-6 levels, and the expression level of IL-6 is also a commonly used indicator for detecting anti-inflammatory effects.
[0067] In the present invention, the inflammatory factor IL-6 secreted by RAW264.7 cells is measured by the lipopolysaccharide (LPS)-induced RAW264.7 inflammation model to evaluate the anti-inflammatory efficacy of the test substance. As shown in the examples, the various fermentation products disclosed herein can reduce the amount of IL-6 released by RAW264.7 cells induced by LPS, and their anti-inflammatory effects are similar to or even better than dexamethasone, especially the compound fermentation products of hops, ophiopogon japonicus, Pseudostellaria heterophylla and crystal sugar grass, which significantly reduce the amount of IL-6 released by RAW264.7 cells induced by LPS, and have an anti-inflammatory effect better than dexamethasone.
[0068] Composition
[0069] The present invention also relates to a composition comprising the Chinese herbal fermentation product disclosed herein, such as a cosmetic composition, a skin care composition or a pharmaceutical composition. The Chinese herbal fermentation product or composition disclosed herein can be used to prevent, reduce or improve inflammation (such as skin inflammation), and to prepare a medicine, cosmetic or skin care product with anti-inflammatory effect.
[0070] The cosmetic / skin care product is suitable for topical application, preferably, applied to the face and / or body of a subject, more preferably, applied to the face, neck, hands or arms of a subject, more preferably, applied to the face and / or neck of a subject (preferably a human). The cosmetic / skin care product may also contain at least one additional cosmetic ingredient, which may be at least one excipient and / or at least one additional cosmetic active ingredient, as long as such ingredients are compatible therewith. Additional cosmetic ingredients include those commonly used in the prior art, for example, adjuvants (e.g., stabilizers), solubilizers, vitamins, colorants and fragrances; carriers; and / or other cosmetic active ingredients. The effective amount of the carrier may be about 50%-99.99%, about 80%-99.9%, about 90%-98%, or about 90%-95% of the composition.
[0071] The carrier can take a variety of forms, for example, liposomes, microemulsions, oleosomes, microspheres, nanoparticles, cyclodextrin molecular inclusion complexes, microcapsules, and the like.
[0072] The cosmetic / skin care product may take various forms, for example, solutions, suspensions, emulsions, pastes, gels, creams, sprays, serums or ointments, as well as adhesive (or non-adhesive) patches or masks.
[0073] The present invention will be further explained below in conjunction with the accompanying drawings and specific embodiments. It should be understood that the following specific embodiments are only used to illustrate the present invention and are not used to limit the scope of the present invention.
[0074] Example
[0075] Experimental materials, instruments, equipment and statistical analysis methods
[0076] The cell sources in the examples: Kalibikerella meyeri PEY-2 is an endophyte isolated from Rhodiola rosea (collected from the Tibetan Rhodiola rosea planting base of Yibencao) in the laboratory, and RAW264.7 (mouse mononuclear macrophages) was purchased from Zhejiang Meisen Cell Technology Co., Ltd.
[0077] Experimental reagents: Ophiopogon japonicus, hops, Pseudostellaria heterophylla and Rock Candy Herb were provided by Shanghai University of Traditional Chinese Medicine, yeast extract, trypsin and glucose were purchased from OXOID, UK, malt extract medium was purchased from Qingdao Haibo Biotechnology Co., Ltd., dexamethasone and lipopolysaccharide (LPS) were purchased from Sigma-Aldric, DMEM basal medium, FBS fetal bovine serum and IL-6 Mouse ELISA kit were purchased from Thermo Fisher Scientific (China) Co., Ltd.
[0078] Data processing and statistical analysis: The experimental results are the mean plus or minus the standard deviation of the three parallel experimental data. The paired t-test was used to test whether the group differences were statistically significant. The data processing and statistical analysis software used was Graph Prism 9.0.
[0079] Example 1: Isolation, purification and identification of Rhodiola rosea endogenous bacteria
[0080] (1) Sterilization: Take the whole Rhodiola rosea plant and soak it in sodium hypochlorite, 75% ethanol and sterile water in sequence. The concentration of sodium hypochlorite is 1% and the soaking time is 3 minutes. After soaking, the Rhodiola rosea plant is rinsed with sterile water several times to remove sodium hypochlorite and ethanol.
[0081] (2) Cultivation: The flowers, leaves, stems and roots of the Rhodiola rosea plant sterilized in (1) are peeled off and homogenized, and the homogenates of each part are added to 50 mL of malt extract medium containing 0.01% chloramphenicol, and cultured in a shaking incubator at 28° C. and 200 rpm for 2 to 5 days. The medium is sterilized by high temperature and high pressure at 115° C. for 30 min.
[0082] (3) Separation: Use an inoculation loop to take the culture fluid of the homogenate of each part in step (2), and streak inoculate it in YPD agar medium by streaking method, and culture it in a constant temperature incubator at 28°C for 1 to 3 days. The YPD agar medium contains: 20 g / L glucose, 20 g / L tryptone, 10 g / L yeast extract, 15 g / L agar powder, and pH = 5.6 ± 0.2. The medium is sterilized at 115°C and high temperature and high pressure for 30 min.
[0083] (4) Purification: The single colony grown in step (3) was selected and inoculated into a new YPD agar medium and cultured in a constant temperature incubator at 28°C for 24 hours. The purified colony was made into a bacterial suspension with 20% glycerol and frozen at -80°C. The yeast-like strains under microscopic examination were named PEY-1, 2, and 3.
[0084] (5) Identification: The obtained strain was sent to Beijing New Era Zhonghe Technology Co., Ltd. for strain identification. The PEY-2 strain was identified as Meyerozyma caribbica, named Meyerozyma caribbica PEY-2, and was deposited in the China Center for Type Culture Collection (address: No. 299, Bayi Road, Wuchang District, Wuhan City, Hubei Province) on May 17, 2024, with the deposit number of CCTCC M 2024991.
[0085] Example 2: Preparation of hop fermentation broth
[0086] (1) Preparation of primary seed solution: 200 μL of frozen culture solution of Mycobacterium cyperus PEY-2 was inoculated into a 250 mL conical flask containing 50 mL YPD medium on a clean bench, and cultured at 28°C and 200 rpm for 16 h until the bacteria were in the logarithmic growth phase. The above culture medium components were: glucose 20 g / L, tryptone 20 g / L, yeast extract 10 g / L, pH = 5.6 ± 0.2. The culture medium was sterilized at 115°C for 30 min.
[0087] (2) Preparation of secondary seed solution: Take 4 mL of the bacterial suspension in (1) and inoculate it into a 500 mL conical plate containing 100 mL of YPD medium. Cultivate at 28°C and 200 rpm for 16 h.
[0088] (3) Hop fermentation method: Dry and crush the hops, and pass through a 100-mesh sieve to obtain hop powder for later use. Take 50 g of hops with a 100-mesh sieve and place them in a 5L glass fermenter (Shanghai Baoxing BIOTECH-5JGY), add 2.3L of deionized water and mix evenly, and sterilize at 115℃ for 30 minutes. After cooling, inoculate 200mL of secondary seed liquid. 5L tank fermentation process: speed 200rpm, temperature 28℃, ventilation 1.2L / min, pressure 0.02MPa, fermentation cycle 24h. After fermentation, sterilize at 95℃ for 20min.
[0089] (4) Removing impurities and bacteria from the fermentation broth: The fermentation broth obtained in step (3) was centrifuged in a high-speed centrifuge and then separated using a membrane separation device SY-UNR-Lab (50 nm) to obtain a sterile fermentation filtrate.
[0090] Example 3: Preparation of Ophiopogon japonicus fermentation broth
[0091] (1) Preparation of primary and secondary seed solutions: Seed solutions were prepared according to the method of Example 2.
[0092] (2) Ophiopogon japonicus fermentation method: Cut the Ophiopogon japonicus into pieces, dry them in an oven and grind them, then pass them through a 100-mesh sieve to obtain Ophiopogon japonicus powder. Take 50g of the Ophiopogon japonicus powder with a 100-mesh sieve and place it in a 5L glass fermentation tank, add 2.3L deionized water and mix evenly. Then sterilize it at 115℃ and high temperature and high pressure for 30min. After cooling, inoculate 200mL of the secondary seed liquid obtained in step (2). 5L tank fermentation process: rotation speed 200rpm, temperature 28℃, ventilation 1.2L / min, pressure 0.02MPa, fermentation cycle 24h. After fermentation, sterilize it at 95℃ for 20min.
[0093] (3) Removing impurities and bacteria from the fermentation broth: The fermentation broth obtained in step (2) was centrifuged in a high-speed centrifuge and then separated using a membrane separation device SY-UNR-Lab (50 nm) to obtain a sterile fermentation filtrate.
[0094] Example 4: Preparation of Pseudostellaria heterophylla fermentation broth
[0095] (1) Preparation of primary and secondary seed solutions: Seed solutions were prepared according to the method of Example 2.
[0096] (2) Pseudostellariae fermentation method: Dry and crush Pseudostellariaee, and pass through a 100-mesh sieve to obtain Pseudostellariaee powder for use. Take 50g of Pseudostellariaee powder with a 100-mesh sieve and place it in a 5L glass fermentation tank. Add 2.3L of deionized water and mix evenly. Sterilize it at 115℃ and high temperature and high pressure for 30min. After cooling, inoculate 200mL of secondary seed liquid. 5L tank fermentation process: speed 200rpm, temperature 28℃, ventilation 1.2L / min, pressure 0.02MPa, fermentation cycle 24h. After fermentation, sterilize it at 95℃ for 20min.
[0097] (3) Fermentation broth was purified and sterilized according to the method in Example 2.
[0098] Example 5: Preparation of Rock Sugar Grass Fermentation Liquid
[0099] (1) Preparation of primary and secondary seed solutions: Seed solutions were prepared according to the method of Example 2.
[0100] (2) Fermentation method of rock sugar grass: dry and crush the rock sugar grass, and pass it through a 100-mesh sieve to obtain rock sugar grass powder for use. Take 50g of the rock sugar grass powder with a 100-mesh sieve and place it in a 5L glass fermentation tank, add 2.3L of deionized water and mix evenly, and sterilize it at 115℃ for 30min. After cooling, inoculate 200mL of secondary seed liquid. 5L tank fermentation process: speed 200rpm, temperature 28℃, ventilation 1.2L / min, pressure 0.02MPa, fermentation cycle 24h. After fermentation, sterilize it at 95℃ for 20min.
[0101] (3) Fermentation broth was purified and sterilized according to the method in Example 2.
[0102] Comparative Example 1: According to the method of Example 2, sterile water was used instead of bacterial suspension for inoculation.
[0103] Comparative Example 2: According to the method of Example 3, sterile water was used instead of bacterial suspension for inoculation.
[0104] Comparative Example 3: According to the method of Example 4, sterile water was used instead of bacterial suspension for inoculation.
[0105] Comparative Example 4: According to the method of Example 5, sterile water was used instead of bacterial suspension for inoculation.
[0106] 4 kinds of Chinese herbal medicines are fermented in different proportions
[0107] Embodiment 6: After drying, crushing and passing through a 100-mesh sieve to obtain powder, hops, ophiopogon japonicus, pseudoginseng and rock sugar grass were mixed in a weight ratio of 4:2:1:1. The total mass of the mixture was 50g, placed in a 5L glass fermenter, 2.3L deionized water was added and mixed evenly, and sterilized at 115℃ for 30min. After cooling, 200mL of secondary seed liquid was inoculated. 5L tank fermentation process: speed 200rpm, temperature 28℃, ventilation 1.2L / min, pressure 0.02MPa, alkali solution to control pH at 5.2±0.2, fermentation cycle 24h. After fermentation, sterilize at 95℃ for 20min.
[0108] Embodiment 7: Hops, Ophiopogon japonicus, Radix Pseudostellariae and Herba Crystallis are mixed in the same ratio of 4:1:2:1. The total mass of the mixture is 50g. Place it in a 5L glass fermenter, add 2.3L deionized water and mix evenly. Sterilize it at 115℃ for 30min. After cooling, inoculate 200mL of secondary seed liquid. 5L tank fermentation process: speed 200rpm, temperature 28℃, ventilation 1.2L / min, pressure 0.02MPa, alkali solution to control pH at 5.2±0.2, fermentation cycle 24h. After fermentation, sterilize at 95℃ for 20min.
[0109] Embodiment 8: Hops, Ophiopogon japonicus, Radix Pseudostellariae and Herba Crystallis are mixed in the same ratio of 4:1:1:2. The total mass of the mixture is 50g. Place it in a 5L glass fermenter, add 2.3L deionized water and mix evenly. Sterilize it at 115℃ for 30min. After cooling, inoculate 200mL of secondary seed liquid. 5L tank fermentation process: speed 200rpm, temperature 28℃, ventilation 1.2L / min, pressure 0.02MPa, alkali solution to control pH at 5.2±0.2, fermentation cycle 24h. After fermentation, sterilize at 95℃ for 20min.
[0110] Comparative Example 5: According to the method of Example 6, sterile water was used instead of bacterial suspension for inoculation.
[0111] Comparative Example 6: According to the method of Example 7, sterile water was used instead of bacterial suspension for inoculation.
[0112] Comparative Example 7: According to the method of Example 8, sterile water was used instead of bacterial suspension for inoculation.
[0113] Compound fermentation broth at different fermentation times
[0114] Embodiment 9: Fermentation was carried out according to the method of Example 8, except that the fermentation period was changed to 16 h.
[0115] Embodiment 10: Fermentation was carried out according to the method of Example 8, except that the fermentation period was changed to 32 h.
[0116] Embodiment 11: Fermentation was carried out according to the method of Example 8, except that the fermentation period was changed to 40 h.
[0117] Comparative Example 8: According to the method of Example 9, sterile water was used instead of bacterial suspension for inoculation.
[0118] Comparative Example 9: According to the method of Example 10, sterile water was used instead of bacterial suspension for inoculation.
[0119] Comparative Example 10: According to the method of Example 11, sterile water was used instead of bacterial suspension for inoculation.
[0120] Compound fermentation broth at different temperatures
[0121] Embodiment 12:Hops, Ophiopogon japonicus, Radix Pseudostellariae and Herba Glechomae are mixed in a ratio of 4:1:1:2, with a total weight of 50g, placed in a 50L glass fermenter and added with 2.3L deionized water, sterilized at 115℃ for 30min. After cooling, 200mL of secondary seed liquid is added, and the fermentation process is as follows: temperature 25℃, speed 200rpm, pressure 0.002Mpa, ventilation volume 1.2L / min, alkali solution to control pH at 5.2±0.2, and fermentation cycle 32h. After fermentation, sterilize at 100℃ for 20min.
[0122] Embodiment 13: According to the method of Example 12, the fermentation temperature was adjusted to 30°C.
[0123] Embodiment 14: According to the method of Example 12, the fermentation temperature was adjusted to 33°C.
[0124] Embodiment 15: According to the method of Example 12, the fermentation temperature was adjusted to 37°C.
[0125] Comparative Example 11: According to the method of Example 12, sterile water is used instead of the secondary seed liquid for inoculation.
[0126] Comparative Example 12: According to the method of Example 13, sterile water is used instead of the secondary seed liquid for inoculation.
[0127] Comparative Example 13: According to the method of Example 14, sterile water is used instead of the secondary seed liquid for inoculation.
[0128] Comparative Example 14: According to the method of Example 15, sterile water is used instead of the secondary seed liquid for inoculation.
[0129] Embodiment 16: Determination of inflammatory factors in RAW264.7 cells
[0130] (1) Cell culture: RAW264.7 cells were grown in complete medium, i.e., DMEM containing 10% FBS and 1% double antibody, at 37°C and 5% CO. 2 incubator.
[0131] (2) Cell plating and sample processing: 100 μL of 2×10 4RAW264.7 cells were added to each well of the sample group and 200 μL of 100 ng / mL dexamethasone was added to each well of the positive control group. The model group and the blank group were incubated with only culture medium for 24 hours. After the culture medium was discarded, 200 μL of 1 μg / mL LPS was added for 6 hours, and the blank group was replaced with 200 μL of culture medium.
[0132] (3) Cytotoxicity assay: 100 μL of CCK-8 solution (enhanced CCK-8 and DMEM mixed at a ratio of 1:10) was added to each well. After being placed in an incubator for 2 h, the absorbance at 450 nm was measured. The absorbance value obtained was used to calculate the cell survival rate using formula (1):
[0133] Formula (1): Cell survival rate % = As / Ab × 100%
[0134] Note: As is the absorbance of the sample group; Ab is the absorbance of the blank control group
[0135] (4) Determination of inflammatory factor IL-6: The supernatant in step (2) was taken and the IL-6 content in the supernatant was detected using IL-6 Mouse ELISA kit (Thermo Fisher Scientific).
[0136] Technical Effects
[0137] (1) Improvement of anti-inflammatory effects of four Chinese herbal medicines after fermentation
[0138] The anti-inflammatory effects of hops, ophiopogon japonicus, radix pseudoginseng and rock candy grass after fermentation by Kalibik Mayer yeast PEY-2 were significantly improved. Under the same conditions, the anti-inflammatory effect of the fermented hops fermentation filtrate at a concentration of 0.5% was close to that of 100ng / mL dexamethasone, and the content of interleukin factor IL-6 was reduced from 22485.2pg / mL to 9631pg / mL. The anti-inflammatory effects of ophiopogon japonicus, radix pseudoginseng and rock candy grass after fermentation were also close to that of dexamethasone, and the content of IL-6 could be controlled at around 13000-14000.
[0139] Table 1. Anti-inflammatory effects of four Chinese herbal medicines before and after fermentation
[0140]
[0141]
[0142] The loading concentration of 0.5% means that the fermentation broth obtained in the examples or comparative examples is diluted from 100% of the fermentation broth stock solution to 0.5% (the same below).
[0143] (2) Improvement of anti-inflammatory effects after synergistic fermentation of four Chinese herbal medicines in different proportions
[0144] Hops, Radix Ophiopogonis, Radix Pseudostellariae and Herba Xanthophytae were fermented in a ratio of 4:2:1:1, 4:1:2:1 and 4:1:1:2, and it was found that the fermentation of the four herbs had a stronger effect than the hops fermentation liquid with the strongest anti-inflammatory effect, that is, the IL-6 concentration of the fermented liquid after treating the cells was greater than the anti-inflammatory effect of Example 2. This shows that the combination of the four herbs has a synergistic effect with the Kalibiker yeast PEY-2, and the fermentation at a ratio of 4:1:1:2 has the strongest anti-inflammatory effect, which can reduce the IL-6 concentration to 7853.7 pg / mL, and its effect is stronger than 100 ng / mL of dexamethasone.
[0145] Table 2. Anti-inflammatory effects of different compatibility ratios
[0146]
[0147]
[0148] (3) Study on the anti-inflammatory effect of fermented compound at different fermentation times
[0149] Example 8, which had the best effect in the experiment of exploring the compatibility ratio, was used as the preliminary fermentation condition, and different fermentation times were further explored based on the compatibility ratio of 4:1:1:2. During the fermentation period of 16 to 40 hours, the anti-inflammatory effect of the fermentation broth showed a trend of first increasing and then decreasing, with the strongest anti-inflammatory effect reached at 32 hours. That is, continuous fermentation of 32 hours using Kalibik Mayer yeast PEY-2 at a compatibility ratio of 4:1:1:2 can reduce IL-6 from 24381.7 pg / mL to 6993.8 pg / mL, which is also significantly stronger than 100 ng / mL of dexamethasone.
[0150] Table 3. Anti-inflammatory effects of different fermentation times
[0151]
[0152] (4) Study on the anti-inflammatory effect of fermented compound at different fermentation temperatures
[0153] Example 10, which has the strongest anti-inflammatory effect in the experiment of exploring the fermentation time, was used as the basic fermentation condition in the exploratory experiment, that is, on the basis of continuous fermentation of 32 hours using Kalibik Mayer yeast PEY-2 under the conditions of a compatibility ratio of 4:1:1:2, the effects of different fermentation temperatures (25°C to 37°C) on the anti-inflammatory effect were explored respectively. When the fermentation temperature increases from low to high, its anti-inflammatory efficacy also shows a trend of increasing first and then decreasing, reaching the best anti-inflammatory effect at 30°C. That is, using Kalibik Mayer yeast PEY-2 at a compatibility ratio of 4:1:1:2 for continuous fermentation at 30°C for 32 hours can reduce IL-6 from 23984.5pg / mL to 6715.6pg / mL, which is also significantly stronger than 100ng / mL of dexamethasone.
[0154] Table 4. Anti-inflammatory effects of different fermentation temperatures
[0155]
[0156] According to the results obtained in all the above embodiments, hops, ophiopogon japonicus, Pseudostellaria heterophylla and rock sugar grass are mixed in a ratio of 4:1:1:2, deionized water is added to a total liquid-to-solid ratio of 20g / L, and sterilized at 115°C for 30min. The speed is set to 200rpm, the temperature is 30°C, the ventilation is 1.2L / min, the pressure is 0.02MPa, and after cooling, 8% of the secondary seed liquid accounting for the total fermentation volume is connected, the alkali solution controls the pH at 5.2±0.2, and the fermentation cycle is 32h. The compound fermentation broth obtained under this process can have a strong anti-inflammatory effect, that is, it can reduce IL-6 from 23984.5pg / mL to 6715.6pg / mL, which is stronger than the effect of 100ng / mL dexamethasone (9271.9pg / mL).
[0157] Those skilled in the art will further recognize that the present invention may be implemented in other specific forms without departing from its spirit or central features. Since the foregoing description of the present invention discloses only exemplary embodiments thereof, it should be understood that other variations are considered to be within the scope of the present invention. Therefore, the present invention is not limited to the specific embodiments described in detail herein. On the contrary, the scope and content of the present invention should be indicated with reference to the appended claims.
Claims
1. A method for fermenting Chinese herbal medicine using Meyerozyma caribbica isolated from Rhodiola rosea, wherein include: The herbal material is fermented in the presence of the Saccharomyces cerevisiae at 25°C-40°C for 10-50 hours.
2. The method of claim 1, wherein the Chinese herbal medicine material is washed, dried, chopped and / or crushed.
3. The method according to claim 1 or 2, wherein the Chinese herbal medicine material is sieved through a sieve, preferably, the sieve is a 100-mesh sieve.
4. The method according to any one of claims 1 to 3, wherein the Chinese herbal medicine material is a suspension or slurry obtained by mixing the Chinese herbal medicine with water, Preferably, the total solid-to-liquid ratio of the suspension or slurry is 15-25 g / L, such as 20 g / L. Preferably, the suspension or slurry is sterilized by high temperature and high pressure.
5. The method according to any one of claims 1 to 4, wherein the Chinese herbal medicine is selected from hops, ophiopogon japonicus, pseudostellaria and rock sugar grass.
6. The method according to claim 5, wherein the Chinese herbal medicine is a combination of hops, ophiopogon japonicus, Pseudostellaria heterophylla and crystal sugar grass, Preferably, the weight ratio of hops to ophiopogon japonicus, Pseudostellaria heterophylla and Herba Xanthophyllae in the Chinese herbal medicine material is 1:1; More preferably, the weight ratio of hops, ophiopogon japonicus, pseudostellaria and rock sugar grass in the Chinese herbal medicine materials is 4:2:1:1, 4:1:2:1 or 4:1:1:2, more preferably 4:1:1:
2.
7. The method according to any one of claims 1 to 6, wherein the Kalibik Maye Saccharomyces cerevisiae is Kalibik Maye Saccharomyces cerevisiae PEY-2, which was deposited in China Center for Type Culture Collection on May 17, 2024, with strain accession number CCTCC M2024991.
8. The method according to any one of claims 1 to 7, wherein the Mayer Saccharomyces californica is provided in the form of a bacterial suspension of a culture, and optionally, the bacterial suspension is a secondary seed liquid after seed expansion culture. 9 . The method of claim 8 , wherein the culture is a culture of the Mayerella calibiensis in a YPD medium.
10. The method according to any one of claims 1 to 9, wherein a suspension of Saccharomyces cerevisiae is inoculated into a fermentation device containing the material of the Chinese herbal medicine for fermentation, Preferably, the bacterial suspension is inoculated into the fermentation device at 8% of the total fermentation volume.
11. The method of claim 10, wherein the fermentation device is a fermenter, such as a rotary fermenter.
12. The method of any one of claims 1-11, wherein the fermentation is carried out at a temperature of 25-37°C, preferably at a temperature of 30°C.
13. The method according to any one of claims 1 to 12, wherein the fermentation time is 16 hours to 40 hours, preferably 32 hours.
14. The method according to any one of claims 1 to 12, further comprising removing impurities and bacteria from the fermentation broth after fermentation, for example, by centrifugation and membrane separation.
15. The method of claim 1, include: a) growing the Meyer yeast Kalibik isolated from Rhodiola rosea in a culture medium to prepare a bacterial suspension; b) adding Chinese herbal medicine materials into the fermentation device; and c) inoculating the bacterial suspension from step a) into a fermentation device for fermentation.
16. The method of claim 15, wherein the Chinese herbal medicine is a combination of hops, ophiopogon japonicus, Pseudostellaria heterophylla and rock sugar grass, and the fermentation is carried out at a temperature of 30°C for 32 hours. Preferably, the weight ratio of hops, ophiopogon japonicus, pseudoginseng and rock sugar grass in the Chinese herbal medicine materials is 4:2:1:1, 4:1:2:1 or 4:1:1:2, more preferably 4:1:1:
2.
17. A Chinese herbal medicine fermentation product obtained by the method according to any one of claims 1 to 16.
18. The Chinese herbal medicine fermentation product according to claim 17, wherein the Chinese herbal medicine is: (a) Hops; (b) Ophiopogon japonicus; (c) Pseudostellaria heterophylla; (d) rock candy grass; (e) a combination of hops, ophiopogon japonicus, Pseudostellaria heterophylla and rock candy grass, Preferably, the weight ratio of hops to ophiopogon japonicus, Pseudostellaria heterophylla and Herba Xanthophyllae in the Chinese herbal medicine material is 1:1; More preferably, the weight ratio of hops, ophiopogon japonicus, pseudostellaria and rock sugar grass in the Chinese herbal medicine materials is 4:2:1:1, 4:1:2:1 or 4:1:1:2, preferably 4:1:1:
2.
19. A pharmaceutical composition comprising the Chinese herbal medicine fermentation product according to claim 17 or 18.
20. A cosmetic composition comprising the Chinese herbal medicine fermentation product according to claim 17 or 18.
21. The cosmetic composition of claim 20, further comprising a cosmetically acceptable auxiliary material or a dermatologically acceptable carrier, and optionally further cosmetically active ingredients, such as vitamins, colorants or fragrances.
22. The cosmetic composition of claim 20 or 21, which is formulated in the form of a solution, suspension, emulsion, paste, gel, cream, spray or essence, or incorporated into a facial mask.
23. Use of the Chinese herbal medicine fermentation product according to claim 17 or 18 in the preparation of a medicament for preventing, alleviating or improving skin inflammation.
24. Use of the Chinese herbal medicine fermentation product according to claim 17 or 18 in the preparation of skin care products or cosmetics with anti-inflammatory effects.
25. A Kalibik Mayer yeast isolated from Rhodiola rosea, which was deposited in the China Center for Type Culture Collection on May 17, 2024, and the strain collection number is CCTCC M2024991.
26. Use of the Mayer Saccharomyces calibikel according to claim 25 in preparing fermentation products of Chinese herbal medicine.
